Advances in Cancer: Research & Treatment (ACRT) is a peer-reviewed, open access journal that publishes original research articles, review articles, and case studies in all areas of cancer research and effective treatments.
ISSN: 2326-702X
Everson Luiz de Almeida Artifon, University of Sao Paulo, Brazil
Richard J Bende, Academic Medical Center, University of Amsterdam, Netherlands
David Cella, Northwestern University Feinberg School of Medicine, Chicago, USA
Karis K. F. Cheng, Alice Lee Centre for Nursing Studies, National University of Singapore, Singapore
Abhijit De, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, India
Walter Jäger, University of Vienna, Austria
Phillip Koeffler, David Geffen School of Medicine at ULCA, USA
Vassilios A. Lachanas, University Hospital of Larissa, Greece
Maurie Markman, Cancer Treatment Centers of America, USA
Morito Monden, Hospital Director, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Japan
Sandra Marisa Pelloso, State University of Maringá, Brazil
Patricia Poulin, University of Ottawa, Canada
Felisbina Luisa Queiroga, University of Trás-os-Montes and Alto Douro, Portugal
Muhammad Wasif Saif, Leader; Experimental Therapeutics Program, Tufts Medical Center, USA
Arjun Sahgal, Sunnybrook Health Sciences Centre, University of Toronto, Canada
Nagahiro G. Saijo, Deputy Director of the National Cancer Center Hospital East in Chiba, Japan
Alexander Scherbakov, Russian Academy of Medical Sciences, Russia
Marta Herreros Villanueva, Mayo Clinic, Rochester, Minnesota, USA
JawYuan Wang, Kaohsiung Medical University, Taiwan
Demosthenes E. Ziogas, University of Ioannina, Greece
Masao Sato, Tokushima Bunri University, Japan
Amr Amin, United Arab Emirates University, United Arab Emirates
Manuscripts will be evaluated for originality, significance, clarity, and contribution. Submitted manuscript must not have been previously published or currently submitted for publication elsewhere. All submissions will go through centralized database for classification and internal administration purposes. Once classified, papers will be directed to the appropriate Editor. All submissions are read by at least one of the Editors. Every effort is made to judge the merits of manuscripts. Editor will refer the manuscript to 2-3 external reviewers in a full double-blind peer review process and will send a summary of review back to the author(s). Editors have full authority to make one of the following decisions: – Publish without modification – Accept with revision – Accept with major revision – Reject Please note: An invitation to accept with major revision does not imply a promise of subsequent publication, however, it is an indication of a positive reaction from reviewers and there is a possibility of publication. Editors may take note of comments and advice made by reviewers that are not intended to be shared with authors. For all accept with revision, only editor in chief will review the revised manuscript before giving the final accept/reject decision.
Important Disclaimer
Neither this Journal nor IBIMA Publishing accepts any liability whatsoever for the consequences of any such inaccurate, misleading data, opinions, or statements. Although every effort is made by the journal and the editorial board of this open access journal to see that no inaccurate, misleading data, opinions, or statements appear in the published article. It has to be clear that the data, opinions, and statements appearing in the articles are the sole responsibility of the author(s).
Manuscript Submission
Indicate the journal to which you want to submit the manuscript. Use a major word processing software such as Microsoft word, open office word,…etc. to write and submit your manuscript. PDF submission are also allowed.
This section should follow keywords. This section should provide background of the study and highlight research motivation.
References to previously published research studies must in Harvard style. Author(s) should make every effort to ensure completeness, accuracy and consistency of each reference.
Examples:
– In a research study by ackoff (1961) …..
– Gibberd et al (1991) mentioned……
– In the book by Dunlop and Williams (1989) ……
References
References section should be at the end of the manuscript. References to previously published research studies must in Harvard style. References should be arranged alphabetically without numbers. Keep one black line between each two references. Please follow the examples below.
Journal Articles
Last name, initials. (year) ‘Article title with only first letter upper case,’ Journal name, vol (issue no.), pages.
Example: Articles with one author
Goodwin, G. M. (2009) “Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British association for psychopharmacology,” Journal of Psychopharmacology, 23 (4) 346—388.
Example: Articles with two authors
Y. Q. Liang, Y. Q. and Tang, X. C. (2006) “Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats,” Acta Pharmacologica Sinica, 27 (9) 1127—1136. Example: Articles with more than two authors Kountouras, J, Billing, B. H. and Scheuer, P. J. (1984) “Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat,” British Journal of Experimental Pathology, 65 (3) 305—311.
Books
Paxinos, G. and Franklin, K. B. J. (2001) The Mouse Brain in Stereotaxic Coordinates, Academic Press, San Diego, Calif, USA. Conference Paper Zhou, M. Ciobanu, Pavon-Djavid, G., Gueguen, V., and Migonney, V. (2007) “Morphology and adhesion of human fibroblast cells cultured on bioactive polymer grafted ligament prosthesis,” Conference Proceedings of IEEE Engineering in Medicine and Biology Society, (2007), 5115—5118.
Copyright Notice
Authors who publish in any IBIMA Publishing open access journal retain the copyright of their work under a Creative Commons Attribution 3.0 Unported License, which allows the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited. No permission is required from the authors or the publishers. While authors retain copyright of their work with first publication rights granted to IBIMA Publishing, authors are required to transfer copyrights associated with commercial use to this Publisher. Revenues produced from commercial sales and distribution of published articles are used to maintain reduced publication fees and charges.
Advances in Cancer: Research & Treatment (ACRT) is an open access Journal. Open access journals are those that provide immediate and free access of all published full-text articles to interested readers around the world. Open access provide readers with the ability to view, save, print, copy, distribute, transmit, and adapt any published article without fee-based subscriptions. Open access publishing (OAP) can provide several benefits to participating authors. It helps in maximizing the dissemination and impact of research by making it available to all readers worldwide. Further, recently published literature suggest that OAP increases the chance of more citations of the published work, which in turn can be translated into more recognition of research. More importantly, OAP promotes and encourages cumulative research and knowledge building worldwide by providing easy, enhanced, and accelerated access to research. Publishing an article in ACRT requires payment of the manuscript processing charges once the manuscript accepted for publication. The payment is to be made by one of the authors, their university/organization, or funding entity. The manuscript processing charges are designed to allow publishers to recover manuscript processing expenses and the cost of making the full-text available on the Internet to all interested researchers.
Manuscript Charges:
| Manuscript Type | Charges |
| Research Article, Clinical Study, or Review Article | EUR €295 |
Publishing research work and experiment findings is a celebration of significant efforts by a scholar who shares results with other scholars around the world. More importantly, it is a contribution to the body of knowledge towards to humanity in the subject matter. Accordingly, IBIMA publishing takes the matter of publication ethics seriously and takes the several measures to address this important matter in scientific research in all its journals.
Strictly blind peer-review process applies to all manuscripts. This ensures the fair evaluation of submitted manuscripts and the contribution to the body of knowledge of the subject matter.
The submitted manuscript must be an original work and sole property of the Author(s), and the manuscript should not be published elsewhere nor should it be currently under consideration for publication by another journal. Manuscripts that are found to be published before or under consideration/review elsewhere will be rejected immediately and authors will be banned for a period of twelve months from submitting any new manuscript to any IBIMA Publishing Journal regardless whether the newly submitted manuscript is authored individually or co-authored with others whether involved or not in the previous violation. That ban will be extended to the editorial board of any journal published by IBIMA Publishing. Should the violation be repeated after the twelve months ban period, violating author(s) will be banned for three years from submitting any manuscript to any of IBIMA Publishing Journals. The only two exceptions are first if that the manuscript was presented previously at an IBIMA Conference and treated as an early stage of work in progress that is fully developed later on and submitted to IBIMA Publishing Journal. Second, the submitted manuscript builds on previously published articles elsewhere by the same author(s). In this case, author(s) are obligated to show more significant development in the submitted manuscript than the original published article and also to show that the original article is well cited in the submitted manuscript.
IBIMA Publishing subscribes to Crosscheck powered by iThenticate, A plagiarism detection and prevention technology. IBIMA publishing would not tolerate plagiarism and will take the following measures accordingly. First, the manuscript that has been proven to be involved in plagiarism will be immediately rejected along with the immediate rejection of any other manuscript under consideration by any other IBIMA Publishing Journal submitted by the same authors. Second, each author involved in the violating manuscript will be banned for a period of three years from submitting any new manuscript to any IBIMA Publishing Journal regardless whether the newly submitted manuscript is authored individually or co-authored with others whether involved or not in the previous violation. That ban will be extended to the editorial board of any journal published by IBIMA Publishing. Should the violation be repeated after the three years ban period, violating author(s) will be banned for life from submitting any manuscript to any of IBIMA Publishing Journals.
Complains
For any complain with regard to any publishing article, please contact the us at contact@ibimapublishing.com. We’ll acknowledge your e-mail and provide an estimated time to study and address your complain. We will investigate the complaint to classify whether it is administrative (ex. related to procedures, Errors,…) or academic (related to published material from scientific prospective), direct complaint to the right department or editorial board, and take appropriate action.
Journal indexed and/or abstracted in the following databases/resources:
Ulrich’s Periodcals Directory